Toward better understanding and management of chemobrain: the potential utilities of the MemTrax memory test
Open Access
- 17 July 2024
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 24 (1) , 1-7
Abstract
Objective: To study the effects of chemotherapy on cognitive function in breast cancer patients, and to investigate the relationship of MemTrax test of memory and related functions to the FACT-Cog functional self-assessment for the evaluation and management of chemobrain. Methods: In this prospective cohort study, clinical information of pathologically confirmed female breast cancer patients who decided to receive chemotherapy were collected in a questionnaire which was developed for this study and provided as a supplementary file. The FACT-Cog self-assessment and MemTrax test were administered before and after the chemotherapy treatments. Patients with chemobrain were identified using published criteria based on FACT-Cog scores, and MemTrax scores from chemobrain patients were analyzed. Results: Fifty-six patients participated in this study, of which 41 participants completed 4 or more cycles of chemotherapy and were included in the final analyses here. Using the reported high end of minimal clinical differences (10.6 points) of FACT-Cog before and after chemotherapy, 18 patients suffered from chemobrain in this study. In these 18 chemobrain patients, no cognitive impairments were detected by MemTrax, which paradoxically demonstrated an improvement in the normal cognitive range. Conclusion: The cognitive impairment induced by chemotherapy in breast cancer patients is detectable by the FACT-Cog in a Chinese cohort but is not detected by the MemTrax memory test. The fact that the more objective MemTrax could not detect the impairment could alleviate patients’ concerns which in turn would be beneficial for patients’ mental health.Keywords
Funding Information
- Yunnan Provincial Department of Education (2020J0165)
This publication has 30 references indexed in Scilit:
- Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in ChinaAlzheimer's & Dementia, 2023
- Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin EfficacyNeurotherapeutics, 2021
- Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in ratsLife Sciences, 2021
- Chemotherapy-Related NeurotoxicityCurrent Neurology and Neuroscience Reports, 2016
- Therapeutic potential of chemokine signal inhibition for metastatic breast cancerPharmacological Research, 2015
- Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patientsJournal of Clinical Epidemiology, 2014
- Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast CancerValue in Health, 2013
- Renaming “Chemobrain”Cancer Investigation, 2007
- The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based SampleJournal of the American Geriatrics Society, 2003
- “Mini-mental state”Journal of Psychiatric Research, 1975